Publication Library & Research Findings

Filter By Core Concepts
585 Results
Impact Report
Cancer Drug Approvals Grew From 4% of US Total in the 1980s to 27% in 2010-18
September/October 2019
Research Article
A Study on the Application and Use of Artificial Intelligence to Support Drug Development
Clinical Therapeutics
Mary Jo Lamberti, Kenneth Getz
8/1/2019
Research Article
Assessing Biopharmaceutical Company Experience with Patient-centric Initiatives
Clinical Therapeutics
Mary Jo Lamberti, Kenneth Getz
8/1/2019
Research Article
What's Visible Is My Race, What's Invisible Is My Contribution: Understanding the Effects of Race and Color-Blind Racial Attitudes on the Perceived Impact of Microaggressions Toward Asians in the Workplace
Journal of Vocational Behavior
Jennifer Kim
8/1/2019
Commentary
Using Patient Advisory Boards to Solicit Input Into Clinical Trial Design and Execution
Clinical Therapeutics
Kenneth Getz
8/1/2019
Whitepaper
ALPHA Project Unites Global Lupus Community on Barriers to Research, Drug Development, Care, and Access
August 2019
Impact Report
Growth in Rare Disease R&D is Challenging Development Strategy and Execution
July/August 2019
Whitepaper
Summary Report From the Spring 2019 Executive Roundtable on Company Response to ICH E6 (R2)
July 2019
Research Article
Reflections on the Evolution of Patient Engagement in Drug Development
Pharmaceutical Medicine
Kenneth Getz
5/17/2019
Research Article
Assessing the Adoption of Clinical Trial Results Summary Disclosure to Patients and the Public
Expert Review of Clinical Pharmacology
Kenneth Getz
5/15/2019
Impact Report
Adoption of Artificial Intelligence is High Across Drug Development
May/June 2019
Impact Report
Outsourcing Outpaces Internal Spending But Remains Tactical and Reactive
March/April 2019
Research Article
Assessing Outsourcing Oversight Practices and Performance
Therapeutic Innovation & Regulatory Science
Beth Harper, Kenneth Getz
1/21/2019
Research Article
Global Consensus Building and Prioritisation of Fundamental Lupus Challenges; the ALPHA Project
Lupus Science and Medicine
Kenneth Getz
1/1/2019
Impact Report
US Continues to Lead New Drug R&D, But Asia-Pacific is Starting to Rise
January/February 2019
Research Article
The Use of Real World Evidence and Data in Clinical Research and Postapproval Safety Studies
Therapeutic Innovation & Regulatory Science
Mary Jo Lamberti, Kenneth Getz
12/30/2018
Impact Report
Global Biotech Product Development Continues Its Multi-Decade Surge
November/December 2018
Research Article
Global Public Attitudes About Clinical Research and Patient Experiences With Clinical Trials
JAMA Network Open
Kenneth Getz
10/5/2018
Book Chapter
The 360-Degree Experience of Workplace Microaggressions: Who Commits Them? How Do Individuals Respond? What Are the Consequences?
Microaggression Theory: Influence and Implications
Jennifer Kim
9/28/2018
Impact Report
CNS Drugs Take 20% Longer to Develop and to Approve vs. Non-CNS Drugs
September/October 2018
Research Article
Evaluating the Completeness of ClinicalTrials.gov
Therapeutic Innovation & Regulatory Science
Kenneth Getz
7/26/2018
Research Article
Trends Driving Clinical Trials Into Large Clinical Care Settings
Nature Reviews: Drug Discovery
Kenneth Getz
7/20/2018
Impact Report
Rising Protocol Complexity is Hindering Study Performance, Cost and Efficient
July/August 2018
Research Article
Assessing the Financial Benefits of Faster Development Times: The Case of Single-source Versus Multi-vendor Outsourced Biopharmaceutical Manufacturing
Clinical Therapeutics
Joseph DiMasi, Kenneth Getz, Zachary (Zak) Smith
6/1/2018
Impact Report
Patent-to-Launch Time for Orphan Drugs is 2.3 Years Longer vs. Other Drugs
May/June 2018
Commentary
Assessing Pharmaceutical Research and Development Costs
JAMA Internal Medicine
Joseph DiMasi
4/1/2018
Research Article
The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies
Therapeutic Innovation & Regulatory Science
Mary Jo Lamberti, Kenneth Getz
3/28/2018
Research Article
Anticipating New Directions in Contract Clinical Outsourcing
Pharmaceutical Outsourcing
Kenneth Getz
3/20/2018
Impact Report
Clinical and Initiation Process Remains Lengthy and High Inefficient
March/April 2018
Research Article
Evaluating New Data-Driven Approaches Informing Global Investigative Site Selection
Pharmaceutical Outsourcing
2/10/2018
Research Article
Preparing for Precision Medicine
Contract Pharma
Mary Jo Lamberti, Kenneth Getz
1/30/2018
Research Article
Assessing Study Start-Up Practices, Performance and Perceptions Among Sponsors and Contract Research Organizations.
Therapeutic Innovation & Regulatory Science
Mary Jo Lamberti, Beth Harper, Kenneth Getz
1/11/2018
Research Article
Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial
Clinical Infectious Diseases
Joseph DiMasi, Kenneth Getz
1/6/2018
Research Article
Differences in Clinical Research Perceptions and Experiences by Age Subgroup
Therapeutic Innovation & Regulatory Science
Kenneth Getz
1/1/2018
Editorial
Reaching a New Innovation Threshold: How Can We Make It Happen?
Pharma Focus Asia
1/1/2018
Impact Report
eClinical Data Volume and Diversity Pose Increasing Challenges and Delays
January/February 2018
Research Article
Examining and Enabling the Role of Health Care Providers as Patient Engagement Facilitators in Clinical Trials
Clinical Therapeutics
Kenneth Getz
11/1/2017
Impact Report
Real World Evidence Use in Clinical & Post-Approval Research Set to Expand
November/December 2017
Research Article
#PatientVoiceMatters: How Social Media Is Bringing Patients and Biopharmaceutical Companies Together to Improve Drug Development
Clinical Therapeutics
10/31/2017
Research Article
Mapping the Landscape of Patient-Centric Activities Within Clinical Research
Journal of Clinical Therapeutics
Mary Jo Lamberti
10/9/2017
Whitepaper
Manufacturing Strategy for Diverse Biologic Pipelines of the Future
October 2017
Whitepaper
Assessing the Economics of Single-Source vs. Multi-Vendor Manufacturing
October 2017
Commentary
The Use of Social Media in Orphan Drug Development
Clinical Therapeutics
9/20/2017
Research Article
Baseline Assessment of a Global Clinical Investigator Landscape Poised for Structural Change
Therapeutic Innovation & Regulatory Science
Kenneth Getz
9/1/2017
Impact Report
Cardiovascular Drug Approval Rate in the US Fell as Development Time Rose
September/October 2017
Research Article
Insights and Best Practices for Planning and Implementing Patient Advisory Boards
Therapeutic Innovation & Regulatory Science
Kenneth Getz
7/25/2017
Research Article
Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI’s Patient Groups and Clinical Trials Project
Therapeutic Innovation & Regulatory Science
Joseph DiMasi, Kenneth Getz
7/17/2017
Research Article
Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular Entities
Clinical Therapeutics
Kenneth Kaitin, Joseph DiMasi
7/1/2017
Impact Report
ADF Opioid Development, Uptake Tied to Efficacy, Regulatory/Payer Policies
July/August 2017
Research Article
New Benchmarks Characterizing Growth in Protocol Design Complexity
Therapeutic Innovation & Regulatory Science
Kenneth Getz
6/23/2017